March 30, 2017 / 11:29 AM / in 2 years

Biotest says had more requests for deals beyond Creat

FRANKFURT (Reuters) - Biotest (BIOG_p.DE) Chief Executive Bernhard Ehmer told a press conference on Thursday that China’s Creat Group has not been the only suitor approaching Biotest about a deal but it chose to talk to Creat because the proposal was “thought through”.

Creat is seeking to buy the German blood plasma products maker for about 1.2 billion euros ($1.3 billion) including debt following its purchase last year of British peer Bio Products Laboratory.

Reporting by Patricia Weiss; Writing by Ludwig Burger

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below